Management Change/Compensation - Form 8-K

On February 8, 2024, Walgreens Boots Alliance, Inc. (the "Company") announced that John Driscoll, the Company's Executive Vice President and President, U.S. Healthcare, would retire from the Company on or about April 1, 2024. In connection with his retirement, on March 27, 2024, Mr. Driscoll and Walgreen Co., a wholly-owned subsidiary of the Company, entered into a separation and consulting agreement (the "Driscoll Consulting Agreement"), pursuant to which Mr. Driscoll will continue to work an average of approximately 15 hours per week through November 1, 2024 (the period from April 8, 2024 through November 1, 2024, the "Consulting Term"). During the Consulting Term, Mr. Driscoll will be paid $40,000 per month and his outstanding equity awards will continue to vest in accordance with their terms. Mr. Driscoll will also remain eligible for a pro-ratedfiscal 2024 annual bonus. Following the conclusion of the Consulting Term, Mr. Driscoll will receive retirement vesting treatment with respect to his outstanding equity awards pursuant to the terms of the underlying award agreements and as described in the Company's Proxy Statement filed with the Securities and Exchange Commission on December 8, 2023.

The foregoing description of the terms of the Driscoll Consulting Agreement is qualified in its entirety by reference to the full terms of the Driscoll Consulting Agreement, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.